News

Nihon Kohden America was certified as a great workplace on Feb 3 by the independent analysts at Great Place to Work Institute, a global authority on high-trust, high-performance workplace cultures.
Based on endoscopic findings, the condition can be divided into chronic sinusitis with or without nasal polyps.
Dental Sleep Solutions and Blackstone Medical Services have entered into a strategic partnership. The partnership between the organizations provides a seamless home sleep testing model for dental sleep medicine practitioners across the United States, the companies say.
gestational weight gain
In a study to be presented on Feb 4 at 1:15 PM at the Society for Maternal-Fetal Medicine’s annual meeting in Atlanta, researchers will present findings from a study titled "Short and long sleep durations in pregnancy are associated with extremes of gestational weight gain."
Flex Pharma Inc announced today that its extract formulation demonstrated efficacy in treating nocturnal leg cramps (NLC) in a randomized, controlled, blinded study.
Research published in Respirology suggests that sleep apnea may increase the risk of developing chronic kidney disease to a similar extent as hypertension.
Purdue University researchers participated in a multi-institute project that sequenced the genome of the common bed bug, a blood-sucking insect that has reemerged globally as a hardy pest capable of withstanding most major classes of insecticides.
serenium
Health Connexions has partnered with Serenium to bring forward a set of clinically validated biomarkers, a screening tool the companies say will predict and preempt chronic disease.
OptiNose Inc, a privately-held Delaware specialty biopharmaceutical company, today announced that its Norwegian affiliate (OptiNose AS) was selected to receive up to NOK15.9 million (USD$1.8 million) by the Research Council of Norway to study its unique nasal drug delivery technology in the treatment of narcolepsy.
sleep schedule
A study suggests that frequent shifts in sleep timing may be related to adverse metabolic health among non-shift working, midlife women.
NSF model child_open
Designed by Stephen Sheldon, DO, FAAP, the four-sided model displays normal and obstructed breathing functions for an infant up to 12 months on one side and children ages 3 to 12 years of age on the other.
Advanzeon Solutions Inc and its wholly-owned subsidiary Pharmacy Value Management Solutions Inc (PVMS) have retained the services of Debra M. Barnett, MD, to serve as medical director with an emphasis on its sleep apnea and behavioral health programs.
Natus Medical Inc on Jan 27 announced financial results for the three months and full year ended December 31, 2015.
social media
Young adults who spend a lot of time on social media during the day or check it frequently throughout the week are more likely to suffer sleep disturbances than their peers who use social media less, according to research from the University of Pittsburgh School of Medicine.
Many studies have been done on how effective certain pesticides are when they are applied to bed bugs. However, most have not allowed the bed bugs to take a blood meal after being exposed to pesticides, which can change the mortality rates, according to an article in the Journal of Medical Entomology.
menopause insomnia
Sedentary middle-aged Hispanic women in Latin America have significantly worse menopause symptoms than their active counterparts, shows a study of more than 6,000 women across Latin America.
LifeSci Capita LLC, a research-driven investment bank with domain expertise in the life sciences sector, has initiated coverage of Inspire Medical Systems, a privately-held medical device company marketing a neurostimulation device for the treatment of obstructive sleep apnea (OSA).
heart failure
Early diagnosis and treatment of sleep apnea may reduce six-month readmissions for patients hospitalized with heart failure, according to research published online by the American Journal of Cardiology.
womensnore
Almost half of British women say they are not getting enough sleep(43%) and don't feel well-rested when they wake up (48%).
The United States Food and Drug Administration (FDA) on January 22, 2016, proposed a rule to reclassify the cranial electrotherapy stimulator (CES) devices intended to treat insomnia and/or anxiety, a preamendments class III device, into class II (special controls) and subject to premarket notification, and to require the filing of a premarket approval application (PMA) for CES devices intended to treat depression.